Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03230565 · ClinicalTrials.gov registry record · Phase 4
Continuous Infusions vs Scheduled Bolus Infusions
A Phase 4 study of Pain, Postoperative and Surgical Procedure, Unspecified, sponsored by Stanford University.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 240
- Enrollment target
- 1
- Study location
NCT03230565: Recruiting Phase 4 study of Pain, Postoperative and Surgical Procedure, Unspecified, sponsored by Stanford University.
NCT03230565 is a Phase 4 study of Pain, Postoperative and Surgical Procedure, Unspecified that is actively recruiting participants, run by Stanford University. The registered enrollment target is 240 participants, below the 271-participant average among 113 other Pain, Postoperative trials with a reported enrollment target (11% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03230565, a Phase 4 study of Pain, Postoperative and Surgical Procedure, Unspecified, is actively recruiting participants, sponsored by Stanford University.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 240 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of the study is to compare continuous infusions and scheduled bolus infusions for peripheral nerve blocks and their effect on post-surgical pain.
Primary Outcome
Pain scores will be collected using a Numeric Rating Scale (NRS) from 0-10, where 0 is the lowest and 10 is the highest pain level.
Conditions Studied
Interventions
- DRUG Ropivacaine
Study Locations (1)
California
- Stanford University - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2018-06-01 |
| Est. Completion | 2026-12 |
| Phase | Phase 4 |
What NCT03230565 shows while recruiting
NCT03230565 is an interventional study that assigns participants to a tested intervention. The registered 240 participants enrollment target is mid-sized for trials with a published cap, below the 271-participant average among 113 other Pain, Postoperative trials with a reported enrollment target (11% lower).
The record links to 2 conditions, with Pain, Postoperative appearing as the primary indexed condition, and to 1 intervention - of which Ropivacaine is the first listed.
NCT03230565 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03230565 about?
NCT03230565 is a clinical study titled "Continuous Infusions vs Scheduled Bolus Infusions". The goal of the study is to compare continuous infusions and scheduled bolus infusions for peripheral nerve blocks and their effect on post-surgical pain.
What is the current status of trial NCT03230565?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 240 participants. The study started on 2018-06-01. Estimated completion is 2026-12.
What conditions does trial NCT03230565 study?
This clinical trial studies the following conditions: Pain, Postoperative, Surgical Procedure, Unspecified.
What interventions are being tested in trial NCT03230565?
The interventions under investigation include: Ropivacaine (DRUG).
Who is sponsoring clinical trial NCT03230565?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03230565 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain, Postoperative
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03230565's enrollment target sits among peer trials
240 12th of 113 higher than 101 of 113 other Pain, Postoperative trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain, Postoperative trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Management of Postoperative Discomfort in Young Children Following Dental Rehabilitation Under General Anesthesia
RECRUITING · Phase 4
-
Opioids Versus Non-Opioids Postoperative After Knee Arthroscopic Surgery
RECRUITING · Phase 4
-
The Effect of Zolpidem on Outcomes Following Lumbar Spine Fusion
RECRUITING · Phase 4
-
Comparing Analgesic Regimen Effectiveness and Safety for Surgery (CARES) Trial
RECRUITING · Phase 4
-
IPACK on Early Pain Scores After ACL Reconstruction
RECRUITING · Phase 4
-
Liposomal Bupivacaine Versus Lidocaine for Skin Graft Donor Site Pain
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02855554 · 240 participants · NA
Quantitative Cardiac Parametric Mapping
- NCT03399929 · 240 participants
Traumatic Brain Injury and Stroke Long Term Outcome
- NCT03583710 · 240 participants · Phase 3
Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence
- NCT03683680 · 240 participants · NA
Prospectively Collected Pleural Biopsies for Validation of Malignant Pleural Mesothelioma Prognostic Biomarkers
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI